We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SR Pharma Announces Completion of Additional Toxicology Studies for its Systemically Delivered RNAi Compound

News   Jan 30, 2007

 
SR Pharma Announces Completion of Additional Toxicology Studies for its Systemically Delivered RNAi Compound
 
 
 

RELATED ARTICLES

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

The "Midlife Crisis" of Molecular Aging

News

Key molecular programs known to promote longevity do not last beyond midlife, according to a study of genomic patterns in human muscle and brain tissue. The study suggests a possible explanation for why the human disease burden increases so sharply from the sixth decade of life.

READ MORE

tRNA a Warning System for Oncoming Epileptic Seizures?

News

Changes in the concentration of specific transfer RNAs, a major class of noncoding RNA, are associated with epilepsy. The findings suggest that tRNA fragments could serve as an early warning system for predicting seizure risk.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE